Elderly patients benefit from second-line cytotoxic chemotherapy: A subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer

Glen J. Weiss, Corey Langer, Rafael Rosell, Nasser Hanna, Frances Shepherd, Lawrence H. Einhorn, Binh Nguyen, Sofia Paul, Patrick McAndrews, Paul A. Bunn, Karen Kelly

Research output: Contribution to journalArticlepeer-review

143 Scopus citations

Fingerprint

Dive into the research topics of 'Elderly patients benefit from second-line cytotoxic chemotherapy: A subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences